Ranbaxy Laboratories Limited (Ranbaxy) launched India’s first new drug, " Synriam" for the treatment of uncomplicated plasmodium falciparum malaria, in adults, opening a new chapter in the history of Research & Development in India. At a function held in New Delhi, Ghulam Nabi Azad, Minister of Health and Family Welfare, Government of India and Vilasrao Deshmukh, Minister of Science & Technology and Earth Sciences, Government of India, unveiled India’s first new drug Synriam with Ranbaxy dedicating the new age cure for malaria to the nation, on World Malaria Day.
The new drug, has been approved by the Drug Controller General of India (DCGI) for marketing in India and conforms to the recommendations of the World Health Organization (WHO) for using combination therapy in malaria. Synriam provides quick relief from most malaria-related symptoms, including fever, and has a high cure rate of over 95 per cent.
It is a historic day for science and technology in India as well as for the pharmaceutical industry in the country, as India today joins the elite and exclusive club of nations of the world that have demonstrated the capability of developing a new drug.